BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14582672)

  • 1. Neurotrophins and their role in pathogenesis of alopecia areata.
    Botchkarev VA
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):195-8. PubMed ID: 14582672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata.
    Ito T
    Clin Dev Immunol; 2013; 2013():348546. PubMed ID: 24151515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
    Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
    Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
    J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response.
    Tobin DJ
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):176-81. PubMed ID: 14582669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
    Paus R; Slominski A; Czarnetzki BM
    Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neurogenic inflammation in the pathogenesis of alopecia areata.
    Shi Y; Wan S; Song X
    J Dermatol; 2024 May; 51(5):621-631. PubMed ID: 38605467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial growth control by neurotrophins: leads and lessons from the hair follicle.
    Botchkarev VA; Botchkareva NV; Peters EM; Paus R
    Prog Brain Res; 2004; 146():493-513. PubMed ID: 14699982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata: What's new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
    Dainichi T; Kabashima K
    J Dermatol Sci; 2017 Apr; 86(1):3-12. PubMed ID: 27765435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata: more than skin deep.
    MacLean KJ; Tidman MJ
    Practitioner; 2013 Sep; 257(1764):29-32, 3. PubMed ID: 24383154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of alopecia areata.
    Hordinsky MK
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S13-5. PubMed ID: 24326541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.
    Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata update.
    Alkhalifah A
    Dermatol Clin; 2013 Jan; 31(1):93-108. PubMed ID: 23159179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair follicle stem cell marker nestin expression in regenerating hair follicles of patients with alopecia areata.
    Amoh Y; Maejima H; Niiyama S; Mii S; Hamada Y; Saito N; Katsuoka K
    Eur J Dermatol; 2011; 21(2):209-12. PubMed ID: 21524985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata susceptibility in rodent models.
    McElwee KJ; Freyschmidt-Paul P; Zöller M; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):182-7. PubMed ID: 14582670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
    Carroll JM; McElwee KJ; E King L; Byrne MC; Sundberg JP
    J Invest Dermatol; 2002 Aug; 119(2):392-402. PubMed ID: 12190862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis.
    Alkhalifah A; Alsantali A; Wang E; McElwee KJ; Shapiro J
    J Am Acad Dermatol; 2010 Feb; 62(2):177-88, quiz 189-90. PubMed ID: 20115945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.